Hooijkaas H - Search Results

1

Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects.

Adriaansen HJ, Hooijkaas H, Kappers-Klunne MC, Hählen K, van't Veer MB, van Dongen JJ. Adriaansen HJ, et al. Among authors: hooijkaas h. Haematol Blood Transfus. 1990;33:41-9. doi: 10.1007/978-3-642-74643-7_7. Haematol Blood Transfus. 1990. PMID: 2323649 No abstract available.

2

Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis.

Knulst AC, Adriaansen HJ, Hählen K, Stigter JC, van den Beemd MW, Hagemeijer A, van Dongen JJ, Hooijkaas H. Knulst AC, et al. Among authors: hooijkaas h. Leukemia. 1993 Apr;7(4):532-6. Leukemia. 1993. PMID: 8464231

3

Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.

van Dongen JJ, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. van Dongen JJ, et al. Among authors: hooijkaas h. Leukemia. 1992;6 Suppl 1:47-59. Leukemia. 1992. PMID: 1548936 Review.

4

Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.

Adriaansen HJ, van Dongen JJ, Kappers-Klunne MC, Hählen K, van 't Veer MB, Wijdenes-de Bresser JH, Holdrinet AC, Harthoorn-Lasthuizen EJ, Abels J, Hooijkaas H. Adriaansen HJ, et al. Among authors: hooijkaas h. Leukemia. 1990 Jun;4(6):404-10. Leukemia. 1990. PMID: 2359340

5

Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.

Hooijkaas H, Hählen K, Adriaansen HJ, Dekker I, van Zanen GE, van Dongen JJ. Hooijkaas H, et al. Blood. 1989 Jul;74(1):416-22. Blood. 1989. PMID: 2752121 Free article.

6

Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.

van Dongen JJ, Krissansen GW, Wolvers-Tettero IL, Comans-Bitter WM, Adriaansen HJ, Hooijkaas H, van Wering ER, Terhorst C. van Dongen JJ, et al. Among authors: hooijkaas h. Blood. 1988 Mar;71(3):603-12. Blood. 1988. PMID: 3278747 Free article.

7

TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics.

Michiels JJ, Adriaansen HJ, Hagemeijer A, Hooijkaas H, van Dongen JJ, Abels J. Michiels JJ, et al. Among authors: hooijkaas h. Br J Haematol. 1988 Apr;68(4):423-6. doi: 10.1111/j.1365-2141.1988.tb04229.x. Br J Haematol. 1988. PMID: 3288272

8

Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.

Adriaansen HJ, Jacobs BC, Kappers-Klunne MC, Hählen K, Hooijkaas H, van Dongen JJ. Adriaansen HJ, et al. Among authors: hooijkaas h. Leukemia. 1993 Mar;7(3):472-81. Leukemia. 1993. PMID: 7680403

9

Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes.

Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJ. Groeneveld K, et al. Among authors: hooijkaas h. Leukemia. 1996 Aug;10(8):1383-9. Leukemia. 1996. PMID: 8709649

10

Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.

van Lochem EG, Wiegers YM, van den Beemd R, Hählen K, van Dongen JJ, Hooijkaas H. van Lochem EG, et al. Among authors: hooijkaas h. Leukemia. 2000 Apr;14(4):688-95. doi: 10.1038/sj.leu.2401749. Leukemia. 2000. PMID: 10764156 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters